Get the Stockscreener App
0.8255
7.48%
-0.0667
After Hours:
.84
0.0145
+1.76%
Lunai Bioworks Inc stock is traded at $0.8255, with a volume of 37,696.
It is down -7.48% in the last 24 hours and down -62.31% over the past month.
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
See More
Previous Close:
$0.8922
Open:
$0.8654
24h Volume:
37,696
Relative Volume:
0.28
Market Cap:
$3.74M
Revenue:
$20,900
Net Income/Loss:
$-128.28M
P/E Ratio:
-0.0135
EPS:
-61.2898
Net Cash Flow:
$-5.26M
1W Performance:
-26.29%
1M Performance:
-62.31%
6M Performance:
-68.04%
1Y Performance:
-91.68%
1-Day Range:
$0.8178
$0.9172
1-Week Range:
$0.8178
$1.68
52-Week Range:
$0.8178
$13.28
Lunai Bioworks Inc Stock (LNAI) Company Profile
Name
Lunai Bioworks Inc
Sector
Industry
Phone
45 39179840
Address
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare LNAI vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNAI
Lunai Bioworks Inc
|
0.8255 | 3.74M | 20,900 | -128.28M | -5.26M | -61.29 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Lunai Bioworks Inc Stock (LNAI) Latest News
Lunai Bioworks Seeks Nasdaq Trading Suspension Amid Probe - The Globe and Mail
Lunai Bioworks Seeks Nasdaq Trading Suspension Amid Probe - TipRanks
Lunai Bioworks asks Nasdaq to halt trading amid alleged irregular short-selling - TradingView
Lunai Bioworks Inc. Reports Material Event - Stock Titan
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Treasure Coast News
Lunai Bioworks corrects a link in its lawsuit p... - pluang.com
Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint - TradingView
Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit - Stock Titan
Lunai Bioworks (LNAI) Surges 9% to $2.40, Testing Key Resistance at $2.52Schiff Line - dars.gov.et
Lunai (LNAI) Earnings Data Review: The Company Reports Its Latest Available Figures in the Latest Reading; Closing Response: The Market Price Declines 3.78% in the Latest ReadingNet Income Trends - vinanet.vn
Lunai Bioworks Ord Shs (LNAI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lunai Bioworks (LNAI) Slips 1.44% to $2.40 as Biotech Traders Eye Key $2.28 SupportTake Profit Levels - vinanet.vn
Lunai Bioworks (LNAI) Slips 1.18% as Shares Test Key Support Near $2.39Strangle Setup - vinanet.vn
Lunai Bioworks signs collaboration with BrainStorm Therapeutics - Investing.com
Lunai Bioworks files amended complaint alleging naked short selling - Investing.com
Lunai Bioworks signs collaboration with BrainStorm Therapeutics By Investing.com - Investing.com UK
Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement With BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 - 富途牛牛
Lunai Bioworks files amended complaint alleging naked short selling By Investing.com - Investing.com India
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit - Yahoo Finance
LNAI Q2 2026 Earnings: Biotech Posts $0.08 Per-Share Loss; Stock Retreats 3.96%Upward Estimate Revision - vinanet.vn
LNAI Q2 2026 Earnings: Reported Loss of -$0.08 Per Share as Stock Climbs 5.45%Analyst Earnings Estimate - vinanet.vn
Lunai Bioworks (LNAI) Declines 4.27%, Testing Key Support Near $1.92Unusual Put Volume - dars.gov.et
LNAI Q2 2026 Earnings: Pre-Revenue Biotech Reports Narrower Loss; Stock Falls 5.21%Retail Earnings Report - vinanet.vn
LNAI: Lunai Bioworks Inc.Financial Overview - Zacks Investment Research
Lunai Bioworks Holds Steady at $2.24: Consolidation Phase Amid Key SupportVolume Rate Change - vinanet.vn
Lunai Bioworks Ord Shs (LNAI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lunai Bioworks Ord Shs (LNAI) Institutional Confidence - TradingKey
Lunai Bioworks Inc. Revenue Breakdown – NASDAQ:LNAI - TradingView
Lunai Bioworks Ord Shs (LNAI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lunai Bioworks Ord Shs (LNAI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LNAI|Lunai Bioworks Ord Shs|Price:2.240|Chg%:-0.090 - TradingKey
Lunai Bioworks(LNAI) Stock Options Chain | Quotes & News - Moomoo
Lunai Bioworks Inc. (LNAI) investor group discloses 9.41% stake in Schedule 13G - Stock Titan
Lunai Bioworks (LNAI) Tests Key Support After 3.4% DeclineIron Condor Alert - vinanet.vn
LNAI Q2 2026 Earnings: Pre-Revenue Biotech Reports Loss of $0.08 Per Share; Stock Climbs 5.3 PointsROA Comparison - vinanet.vn
Lunai Bioworks Inc. (LNAI) Q2 2026 Earnings: Pre-Revenue Biotech Reports Narrowed Loss, Shares SlideEarnings Miss Streak - dars.gov.et
LNAI Q2 2026 Earnings: Biotech Reports Narrowing Loss, Shares Rise 7.1%Debt Analysis Report - dars.gov.et
Lunai Bioworks Q2 2026 Earnings: Loss of $0.08 Per Share as Stock Gains 7.1% on Pipeline Progress - dars.gov.et
RENB SEC FilingsRenovaro 10-K, 10-Q, 8-K Forms - Stock Titan
Lunai Bioworks (LNAI) Slides 9.7%: Key Support Levels in Focus After Sharp DeclineSmart Beta Flow - dars.gov.et
Enterprise value to EBITDA forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Price to earnings forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Price to earnings forward of Lunai Bioworks, Inc. – FWB:2Q5 - TradingView
EBITDA per share of Lunai Bioworks, Inc. – FWB:2Q5 - TradingView
Lunai Bioworks Inc. (LNAI) Q2 2026 Earnings: Modest Loss, Stock Gains on Pipeline OptimismEarnings Miss Alert - dars.gov.et
Lunai Bioworks (LNAI) Revenue BreakdownMain Composition - Moomoo
Enterprise value to EBIT forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Enterprise value to revenue forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Enterprise value to revenue forward of Lunai Bioworks, Inc. – LS:A42CL6 - TradingView
Price to book forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Lunai Bioworks Inc Stock (LNAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):